Avingtrans PLC (LON: AVG) reports strong performance in first half of fiscal year, with focus on Advanced Engineering Systems and potential growth in medical products.
Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced a positive trading update in respect of
Avingtrans plc (LON:AVG) CEO Steve McQuillan joins DirectorsTalk Interviews to discuss interim results for the six months ended 30th November 2023. In this interview Steve talks us through the financial highlights
Avingtrans PLC (LON:AVG), the international engineering group which designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial sectors, has announced its interim results
Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that trading in the first six months
Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that its subsidiary, Magnetica Limited, has signed
Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that on 21 November 2023, the Board
Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that its U.S.-based subsidiary, Hayward Tyler Inc., has been
Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that Stainless Metalcraft (Metalcraft), part of the Group’s
Avingtrans Steve McQuillan & Steve King discuss the financial highlights from their preliminary results, how the divisions are performing, potentially significant market opportunities in the medical market, the acquisition of Slack and Parr and Adaptix, £13 million in the bank and what investors can expect for the rest of the year in this exclusive interview with DirectorsTalk.
© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
